Navigation Links
Endocrine Society calls for large-scale studies to evaluate testosterone therapy risks
Date:2/7/2014

Chevy Chase, MDAccording to a statement issued today by the Endocrine Society, the risks and benefits of testosterone therapy for older men with declining levels of the hormone need to be fully evaluated.

The statement comes in response to recent studies that have raised concerns about the safety of testosterone therapy in older men with a history of heart disease. Two retrospective analyses and one randomized trial supported by the Veterans Health Care System, and the National Institutes of Health found a higher rate of cardiovascular events in men who received testosterone and had preexisting heart problems. The U.S. Food and Drug Administration has announced it plans to evaluate the safety of testosterone therapy.

Testosterone is approved for the treatment of hypogonadism due to known diseases of the testes, pituitary and hypothalamus. Although the use of testosterone therapy is increasing, the treatment has not been approved for the treatment of age-related symptoms or the age-related decline of testosterone levels.

Important safety data are expected from the NIA's ongoing randomized trial examining testosterone in about 800 older men with unequivocally low testosterone levels and accompanying symptoms, including sexual and physical dysfunction. The trial's structure and careful monitoring of cardiovascular events will help provide important safety information.

The Society calls for the development of more large-scale randomized controlled trials to determine the true risks and benefits of testosterone therapy in older men.

In the statement, the Society recommends that middle-aged and older men who are considering testosterone supplementation for age-related declines should be informed of the potential cardiovascular risks. The Society also believes that it may be prudent not to administer testosterone therapy to men who have had a cardiovascular event (such as myocardial infarction, stroke or acute coronary s
'/>"/>

Contact: Jenni Glenn Gingery
jgingery@endocrine.org
301-941-0240
The Endocrine Society
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Chemotherapy effective for patients with resected SCLC or large-cell neuroendocrine carcinoma
2. Simpler lifestyle found to reduce exposure to endocrine-disrupting chemicals
3. Imaging agents predict breast cancer response to endocrine therapy
4. Moffitt Cancer Center researcher & colleagues test new drug for patients with neuroendocrine tumors
5. Researchers craft tool to minimize threat of endocrine disruptors in new chemicals
6. UCLA study finds endocrine disorder is most common cause of elevated calcium levels
7. Endocrine Society announces 2014 Laureate Award winners
8. Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting
9. New American Chemical Society video: Behind the scenes tour of an electronic nose lab
10. The Gerontological Society of America Selects 2012 Fellows
11. Piramal imaging to present data at Society for Nuclear Medicine Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... included Intellicure, Inc., in its Annual Inc. 5000 list of fastest-growing private ... that "only a tiny fraction of the nation's companies have demonstrated such remarkably ...
(Date:9/3/2015)... ... , ... According to an Oncology Nurse Advisor article published on ... oropharyngeal cancer (oral cancer) to be successfully diagnosed and treated for relapses of the ... which have a high rate of success in treatment and elimination of the disease; ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ... 2015: DiabetesSisters is pleased to announce the additional of Carol Wysham, MD, to ... current board members Diana Karczmarczyk, Donna Rice, David Warren, Matt Stella, Tricia Cedotal, ...
(Date:9/3/2015)... ... September 03, 2015 , ... “We ... which can impact the delicate life balance between work and leisure to the ... Jeffrey R. Leaptrott, CEO , A LifeMinder Plus® Emergency Care Document Set duly ...
(Date:9/3/2015)... ... , ... Mum n Me is pleased to announce the launch of its ... gives maximum protection from sun exposure, wind, bugs, and germs. The Mum n Me ... by keeping the cover securely in place. The new car seat cover is made ...
Breaking Medicine News(10 mins):Health News:Inc. 5000 Includes Intellicure, Inc., Two Years in a Row 2Health News:LA Periodontists Discuss Study on Post-Treatment Oral Rinses Used to Test Recurrence of Oral Cancers 2Health News:LA Periodontists Discuss Study on Post-Treatment Oral Rinses Used to Test Recurrence of Oral Cancers 3Health News:Carol H. Wysham, MD, Joins DiabetesSisters Board of Directors 2Health News:LifeMinder Plus® Announces Emergency Care Document Set Giveaway for America 2Health News:LifeMinder Plus® Announces Emergency Care Document Set Giveaway for America 3Health News:Mum n Me Announces New Baby Car Seat Cover 2
... Rare Town Hall Meeting With U.S. Senator Arlen Specter ... CostsPHILADELPHIA, Feb. 18 AARP Pennsylvania, Business Roundtable, National ... Union held a town hall meeting today on the ... in Philadelphia at the National Constitution Center. While in ...
... New research finds misdiagnosis risk goes up as age goes ... boy complaining of numbness at a Detroit emergency room was ... A 24-year-old woman with sharp pain in her left eye ... by ER doctors that she had a migraine. , And ...
... letter to be published in this week,s Journal ... S. Stanley Young, Assistant Director of Bioinformatics at the ... of British Columbia, highlight the statistical limitations of a ... diabetes and abnormal blood level liver,enzyme levels. The earlier ...
... Monthly menstrual cycles produce many ... cramps, headaches and bloating. With more intense, painful ... vomiting also is a symptom. This monthly recurrence ... study in the November/December 2008 issue of General ...
... (2/18/2009) -- Autism Speaks today announced initial results ... Autism Clinical Trials Network (ACTN), the Study of ... fluoxetine was not effective for reducing repetitive behaviors ... compared to placebo (non-medicinal sugar pill). The study ...
... CRH Medical announced today that for the year ended December ... for Colorectal Health compared to 13,461 for the same period ... Program, the Company sold 6,840 units of its CRH O,Regan ... in 2007. The Company trained more than 100 physicians in ...
Cached Medicine News:Health News:Divided We Fail Pushes to Keep Health Care Reform as a Top Priority for Congress and the New Administration 2Health News:Divided We Fail Pushes to Keep Health Care Reform as a Top Priority for Congress and the New Administration 3Health News:ER Less Likely to Diagnose Stroke in Younger Folks 2Health News:ER Less Likely to Diagnose Stroke in Younger Folks 3Health News:Women Only: Cramps, Bloating and Now, Tooth Erosion? 2Health News:Women Only: Cramps, Bloating and Now, Tooth Erosion? 3Health News:Autism Speaks reports Neuropharm's SOFIA results 2Health News:Autism Speaks reports Neuropharm's SOFIA results 3Health News:CRH experiences significant increase in business activity 2
(Date:9/3/2015)... Sept. 3, 2015  VirtualScopics, Inc. (NASDAQ: ... imaging solutions, announced today, they are collaborating with ... new philanthropic, epidemiology study partnering with the Ministry ...  VirtualScopics has teamed up with a cardiac sonographer ... image results will be used to identify children ...
(Date:9/3/2015)... Sept. 3, 2015 Research and Markets ( ... "Investigation Report on China Olmesartan Market, 2010-2019" report ... medoxomil was successfully developed by Sankyo Pharmaceuticals Co., Ltd ... olmesartan medoxomil was approved by FDA to enter the ... best- selling drug in the world after it succeeded ...
(Date:9/3/2015)... , Sep. 03, 2015 ... ) has announced the addition of the ... 2010-2019" report to their offering. ... totally different chemical structure from steroids which ... can also provide analgestic and antipyretic effects ...
Breaking Medicine Technology:VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa 2VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa 3VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa 4China Olmesartan Investigation Market Report 2010-2019 2China Flurbiprofen Market Investigation Report 2010-2019 2
... of evaluable heavily-pretreated patients in the high dose ... tolerated overall.DALLAS, March 5 ACCESS PHARMACEUTICALS, ... safety and efficacy results from its Phase 2 ... heavily pretreated ovarian cancer patients. In this monotherapy ...
... March 4 A new study by researchers at ... essential B vitamins, including B6, B12, and folic acid, ... of the leading causes of vision loss among older ... key omega-3 fatty acids and phytosterols, are also contained ...
Cached Medicine Technology:Access Pharmaceuticals Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results 2Access Pharmaceuticals Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results 3Access Pharmaceuticals Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results 4Harvard Study Shows Folic Acid, B Vitamins in Animi-3(R) May Prevent Vision Loss 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: